BioSpace News Archive

VNRX-9945 Selected as 3rd Generation Hepatitis B Virus Orally Bioavailable CpAM; Clinical Trial Application and Phase 1 Planned for Second Quarter 2021

KaiNexus (www.kainexus.com), the leading continuous improvement software company, has released a free version of its platform in an effort to facilitate international collaboration on improving COVID-19 vaccine administration

Warmer weather and longer days increase outdoor activities. If you are participating in a single activity more than two times a week, consider purchasing a shoe designed for that activity.

Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) (“Mindset” or the “Company”), a biotechnology company focused on developing next generation psychedelic medicines and related technologies...

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs and added new corresponding products to its growing pharmaceutical pipeline.

Agreement Provides Additional Intellectual Property and Clinical Data for Longeveron While Strengthening Research and Development Relationship

Innovega Inc., a company engaged in developing stylish, lightweight, wearable display technology with a panoramic field of view for virtual and augmented reality (AR/VR), has launched a reservations campaign for its upcoming Series A round with its partner, SeedInvest, a leading equity crowdfunding platform

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that management will present at the Oppenheimer & Co. Annual Healthcare Conference which is being held Tuesday, March 16th – Thursday, March 18th, 2021.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease, today announced the appointment of Russ Belden as Acting Chief Commercial Officer.

Health Catalyst, Inc. (“Health Catalyst,”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of the new Healthcare.AI